Search

Displaying results 5241 - 5250 of 8575 in total
  1. Drug

    Mavrilimumab

    go.drugbank.com/drugs/DB12534
    Investigational

    Mavrilimumab has been investigated for the treatment of Rheumatoid Arthritis.

  2. Drug

    AC-430

    go.drugbank.com/drugs/DB12535
    Investigational

    AC430 has been investigated for the treatment of Rheumatoid Arthritis.

  3. Drug

    Tocotrienol

    go.drugbank.com/drugs/DB12647
    Investigational

    Tocotrienol has been investigated for the treatment of Cholesterol Lowering.

  4. Drug

    Nesbuvir

    go.drugbank.com/drugs/DB07238
    Investigational

    Nesbuvir has been investigated for the treatment of Hepatitis C.

  5. Drug

    Emodin

    go.drugbank.com/drugs/DB07715
    Investigational

    Emodin has been investigated for the treatment of Polycystic Kidney.

  6. Drug

    Covax-19™

    go.drugbank.com/drugs/DB15846
    Investigational

    As of June 2020, the vaccine is in Phase 1 trials to evaluate safety and immune responses (NCT04428073). … Covax-19™ was tested in animal studies, and shown to achieve potent antibody and T-cell responses against the COVID-19 spike protein.

  7. Drug

    DTX-101

    go.drugbank.com/drugs/DB17699
    Investigational

    It was previously investigated for the treatment of hemophilia B; however, the clinical development of DTX-101 was discontinued.[L46103]

  8. Drug

    Nitroarginine

    go.drugbank.com/drugs/DB04223
    Investigational

    An inhibitor of nitric oxide synthetase which has been shown to prevent glutamate toxicity. … Nitroarginine has been experimentally tested for its ability to prevent ammonia toxicity and ammonia-induced alterations in brain energy and ammonia metabolites. (Neurochem Res 1995:200(4):451-6)

  9. Drug

    GSK-2636771

    go.drugbank.com/drugs/DB11795
    Investigational

    GSK2636771 has been used in trials studying the treatment of CANCER, LYMPHOMA, Solid Neoplasm, Recurrent Solid Neoplasm, and Advanced Malignant Neoplasm, among others.

  10. Drug

    PF-00610355

    go.drugbank.com/drugs/DB11871
    Investigational

    PF-00610355 has been used in trials studying the treatment of Lung Disease, Moxifloxacin, Pulmonary Disease, Asthma, Bronchial, and Bronchial Diseases, among others.